About
Biologics
Areas of Focus
Categories
Biologics & BiopharmaceuticalBoston & New England
Clinical Trials (14)
View allTotal Trials
14
As Lead Sponsor
10
As Collaborator
4
Total Enrollment
1,233
By Phase
PHASE2: 7PHASE1: 2
By Status
COMPLETED: 8WITHDRAWN: 2TERMINATED: 2RECRUITING: 1ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline14 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT05284214Lead Sponsor
Sargramostim With Ipilimumab Containing Therapy in Patients With Solid Tumors
PHASE2Withdrawn
Started: Jan 31, 2024 · Completed: Sep 30, 2025
NCT05677633Collaborator
Biomarker Validation Following Sargramostim Treatment in Parkinson's Disease
PHASE1Completed
11 participants
Started: Jan 19, 2023 · Completed: Nov 1, 2024
NCT04902703Collaborator
Phase II Trial to Evaluate Safety and Efficacy of GM-CSF/Sargramostim in Alzheimer's Disease
PHASE2Recruiting
42 participants
Started: Jun 1, 2022 · Completed: Oct 31, 2027
NCT05366283Lead Sponsor
Study to Evaluate Pharmacokinetics, Pharmacodynamics, and Safety of Sargramostim Administered Subcutaneously, Intravenously, or by Inhalation
PHASE1Completed
42 participants
Started: Apr 13, 2022 · Completed: Jun 16, 2022
NCT04856176Collaborator
A Study of Sargramostim Plus Pembrolizumab with or Without Pemetrexed in Patients with Advance Non-small Cell Lung Cancer After Completion of Chemoimmunotherapy
PHASE2Terminated
5 participants
Started: Jan 3, 2022 · Completed: Dec 6, 2024
Locations (1)
Headquarters
Lexington, MA, United States
Map
Loading map...